Hysterectomy for Recurrent/Residual Cervical Cancer Following Definitive Radiotherapy. 2020

Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
Department of Obstetrics and Gynecology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan miamiamia1229@gmail.com.

OBJECTIVE Radical hysterectomy has been used for local recurrent or persistent (LR) cervical cancer after radiotherapy (RT), but the rate of serious complications is high and tolerance is low. This study determined the efficacy, safety, and prognostic factors of adjuvant simple hysterectomy in LR cervical cancer post-RT. METHODS A total of 21 patients who underwent hysterectomy for LR cervical cancer post-RT in our Department between May 2007 and September 2018 were included in the study. Primary, definitive RT was performed. Histological response by definitive RT in the extirpated uterus was classified on the basis of histological response criteria: effect (Ef) 0-3. RESULTS The 5-year overall survival (OS) and disease-free survival (DFS) rates were 51.9% and 50.1%, respectively. Ef 1 was significantly associated with poorer prognosis compared to Ef 2 or Ef 3. CONCLUSIONS Adjuvant hysterectomy could be a treatment of choice for LR cervical cancer post-RT.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018714 Radiotherapy, Adjuvant Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Radiotherapy,Adjuvant Radiotherapies,Radiotherapies, Adjuvant

Related Publications

Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
November 1997, Gynecologic oncology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
November 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
November 2011, Gynecologic oncology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
July 1987, Gynecologic oncology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
February 2015, Head & neck,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
October 2021, International journal of clinical oncology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
May 2009, Gynecologic oncology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
January 2022, Frontiers in immunology,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
July 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Tadaharu Nakasone, and Yusuke Taira, and Yuko Shimoji, and Yoshihisa Arakaki, and Tomoko Nakamoto, and Takuma Ooyama, and Wataru Kudaka, and Itomi Kaneshima, and Kumiko Nishihira, and Keiko Mekaru, and Yoichi Aoki
October 2004, Gynecologic oncology,
Copied contents to your clipboard!